Treace Medical Concepts (TMCI) Net Cash Flow (2020 - 2026)
Treace Medical Concepts (TMCI) posted Net Cash Flow of -$1.2 million for Q1 2026, down 138.52% on a QoQ basis from $3.0 million in Q4 2025, and down 157.57% year-over-year from $2.0 million in Q1 2025.
Treace Medical Concepts (TMCI) Net Cash Flow (2020 - 2026) Analysis & Trends
Treace Medical Concepts' Net Cash Flow history runs 7 years deep, the most recent figure standing at -$1.2 million for Q1 2026.
- Quarterly Net Cash Flow fell 157.57% year-over-year to -$1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.8 million (down 194.8% YoY) and the FY2025 annual result came in at -$642000.0, up 60.66% from the prior year.
- Net Cash Flow was -$1.2 million for Q1 2026 at Treace Medical Concepts, down from $3.0 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $10.1 million in Q1 2023 and bottomed at -$69.1 million in Q4 2022.
- A 5-year average of -$5.7 million and a median of -$1.2 million in 2026 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2022 — Net Cash Flow tumbled 1804.94% — and 2025, when it jumped 497.63%.
- Treace Medical Concepts' Net Cash Flow stood at -$69.1 million in 2022, then jumped by 108.26% to $5.7 million in 2023, then tumbled by 113.32% to -$760000.0 in 2024, then soared by 497.63% to $3.0 million in 2025, then plunged by 138.52% to -$1.2 million in 2026.
- Business Quant data shows TMCI's Net Cash Flow at -$1.2 million in Q1 2026, $3.0 million in Q4 2025, and -$366000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -1.70 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.11 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 768.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -503.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -500.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 202.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.19 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Treace Medical Concepts | 261.60 Mn | 209.75 Mn | 37.41 Mn | -1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.16 Mn |
| Mar 31, 2026 | -1.16 Mn |
| Dec 31, 2025 | 3.02 Mn |
| Dec 31, 2025 | 3.02 Mn |
| Sep 30, 2025 | -366,000.00 |
| Sep 30, 2025 | -366,000.00 |
| Jun 30, 2025 | -5.32 Mn |
| Jun 30, 2025 | -5.32 Mn |
| Mar 31, 2025 | 2.02 Mn |
| Mar 31, 2025 | 2.02 Mn |
| Dec 31, 2024 | -760,000.00 |
| Dec 31, 2024 | -760,000.00 |
| Sep 30, 2024 | -6.07 Mn |
| Sep 30, 2024 | -6.07 Mn |
| Jun 30, 2024 | 8.85 Mn |
| Jun 30, 2024 | 8.85 Mn |
| Mar 31, 2024 | -3.65 Mn |
| Mar 31, 2024 | -3.65 Mn |
| Dec 31, 2023 | 5.70 Mn |
| Dec 31, 2023 | 5.70 Mn |